Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

194 / 286 pathways

<
No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
2件: FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
5 Acute myeloid leukemia 💬
2件: FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
7 Acute myeloid leukemia 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
9 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
10 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
12 Acute myeloid leukemia 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
13 Acute myeloid leukemia 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
14 Acute myeloid leukemia 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
15 Adherens junction 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
16 Adherens junction 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
17 Adherens junction 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
18 Adherens junction 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
19 Adherens junction 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
20 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
21 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
22 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
23 Adipocytokine signaling pathway 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
24 Adipocytokine signaling pathway 💬
1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
25 Adipocytokine signaling pathway 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
26 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
27 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D00358 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
28 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D02086 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
29 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D08127 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
30 African trypanosomiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
31 African trypanosomiasis 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
32 African trypanosomiasis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
33 AGE-RAGE signaling pathway in diabetic complications 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
34 AGE-RAGE signaling pathway in diabetic complications 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
35 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
36 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
37 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
38 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
39 Alcoholism 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
40 Alcoholism 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
41 Alcoholism 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
42 Alcoholism 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
43 Alcoholism 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
44 Alcoholism 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
45 Alcoholism 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
46 Alcoholism 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
47 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
48 Allograft rejection 💬
2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
49 Allograft rejection 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
50 Allograft rejection 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
51 Alzheimer disease 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
52 Alzheimer disease 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
53 Alzheimer disease 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
54 Alzheimer disease 💬
1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
55 Alzheimer disease 💬
1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
56 Alzheimer disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
57 Alzheimer disease 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
58 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
59 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
60 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
61 Alzheimer disease 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
62 Alzheimer disease 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
63 Alzheimer disease 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
64 Alzheimer disease 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
65 Alzheimer disease 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
66 Alzheimer disease 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
67 Alzheimer disease 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
68 Alzheimer disease 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
69 Alzheimer disease 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
70 Alzheimer disease 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
71 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
72 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
73 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
74 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
75 Amoebiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76 Amoebiasis 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
77 Amoebiasis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
78 Amphetamine addiction 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
79 Amphetamine addiction 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
80 AMPK signaling pathway 💬
1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
81 AMPK signaling pathway 💬
1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
82 AMPK signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
83 AMPK signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
84 AMPK signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
85 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
86 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
87 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
88 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
89 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
90 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
91 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
92 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
93 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
94 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
95 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
96 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
97 Antifolate resistance 💬
3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
98 Antifolate resistance 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
99 Antifolate resistance 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
100 Antigen processing and presentation 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
101 Antigen processing and presentation 💬
1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Antigen processing and presentation 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
103 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
104 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
105 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
106 Apelin signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
107 Apelin signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
108 Apelin signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
109 Apelin signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
110 Apelin signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
111 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
112 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
113 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
114 Apoptosis 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
115 Apoptosis 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
116 Apoptosis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
117 Apoptosis 💬
1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118 Apoptosis 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
119 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
120 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
121 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
122 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
123 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
124 Arachidonic acid metabolism 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
125 Asthma 💬
2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
126 Asthma 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
127 Asthma 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
128 Autoimmune thyroid disease 💬
1件: IL10 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
129 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
130 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
131 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
132 Autophagy - animal 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
133 Autophagy - animal 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
134 Autophagy - animal 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
135 Autophagy - animal 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
136 Autophagy - animal 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
137 Autophagy - other 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138 Autophagy - other 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139 Autophagy - other 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
140 Axon guidance 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
141 Axon guidance 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
142 Axon guidance 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
143 Axon guidance 💬
1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
144 Axon guidance 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
145 Axon guidance 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
146 Axon guidance 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
147 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
148 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
149 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
150 B cell receptor signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
151 B cell receptor signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
152 Bacterial invasion of epithelial cells 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
153 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
154 Bile secretion 💬
1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
155 Bile secretion 💬
1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
156 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
157 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
158 Bladder cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
159 Bladder cancer 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
160 Bladder cancer 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
161 Bladder cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
162 Bladder cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
163 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
164 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
165 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
166 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
167 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
168 Bladder cancer 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
169 Bladder cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
170 Breast cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
171 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
172 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
173 Breast cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
174 Breast cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
175 Breast cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
176 Breast cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
177 Breast cancer 💬
1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
178 Breast cancer 💬
1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
179 Breast cancer 💬
2件: FLT4, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
180 Breast cancer 💬
2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
181 Breast cancer 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
182 Breast cancer 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
183 Breast cancer 💬
1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
184 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
185 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
186 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
187 Breast cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
188 Breast cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
189 Breast cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
190 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
191 C-type lectin receptor signaling pathway 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
192 C-type lectin receptor signaling pathway 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
193 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
194 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
195 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
196 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
197 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
198 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
199 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
200 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
201 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
202 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
203 Calcium signaling pathway 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
204 Calcium signaling pathway 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
205 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
206 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
207 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
208 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
209 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
210 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
211 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
212 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
213 Calcium signaling pathway 💬
2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
214 Calcium signaling pathway 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
215 Calcium signaling pathway 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
216 Calcium signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
217 Calcium signaling pathway 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
218 Calcium signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
219 cAMP signaling pathway 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
220 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
221 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
222 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
223 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
224 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
225 Cell cycle 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
226 Cell cycle 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
227 Cell cycle 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
228 Cellular senescence 💬
2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
229 Cellular senescence 💬
1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
230 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
231 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
232 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
233 Cellular senescence 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
234 Cellular senescence 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
235 Cellular senescence 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
236 Cellular senescence 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
237 Cellular senescence 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
238 Central carbon metabolism in cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
239 Central carbon metabolism in cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
240 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
241 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
242 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
243 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
244 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
245 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
246 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
247 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
248 Central carbon metabolism in cancer 💬
3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
249 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
250 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
251 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
252 Central carbon metabolism in cancer 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
253 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
254 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
255 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
256 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
257 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
258 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
259 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
260 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
261 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
262 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
263 Chagas disease 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
264 Chagas disease 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
265 Chagas disease 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
266 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
267 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
268 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
269 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
270 Chemical carcinogenesis 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
271 Chemical carcinogenesis 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
272 Chemokine signaling pathway 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
273 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
274 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
275 Chemokine signaling pathway 💬
1件: CCL2 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
276 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
277 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
278 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
279 Choline metabolism in cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
280 Choline metabolism in cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
281 Choline metabolism in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
282 Choline metabolism in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
283 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
284 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
285 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
286 Choline metabolism in cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
287 Choline metabolism in cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
288 Choline metabolism in cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
289 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
290 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
291 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
292 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
293 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
294 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
295 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
296 Cholinergic synapse 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
297 Cholinergic synapse 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
298 Cholinergic synapse 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
299 Chronic myeloid leukemia 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
300 Chronic myeloid leukemia 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
301 Chronic myeloid leukemia 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
302 Chronic myeloid leukemia 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
303 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
304 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
305 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
306 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
307 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
308 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
309 Cocaine addiction 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
310 Cocaine addiction 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
311 Colorectal cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
312 Colorectal cancer 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
313 Colorectal cancer 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
314 Colorectal cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
315 Colorectal cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
316 Colorectal cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
317 Colorectal cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
318 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
319 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
320 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
321 Colorectal cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
322 Colorectal cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323 Colorectal cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
324 Coronavirus disease - COVID-19 💬
4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
325 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
326 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
327 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
328 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
329 Coronavirus disease - COVID-19 💬
2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
330 Coronavirus disease - COVID-19 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
331 Coronavirus disease - COVID-19 💬
1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
332 Coronavirus disease - COVID-19 💬
1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
333 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
334 Cushing syndrome 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
335 Cushing syndrome 💬
1件: BRAF 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
336 Cushing syndrome 💬
1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
337 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
338 Cushing syndrome 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
339 Cushing syndrome 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
340 Cushing syndrome 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
341 Cushing syndrome 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
342 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
343 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
344 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
345 Cytokine-cytokine receptor interaction 💬
1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
346 Cytokine-cytokine receptor interaction 💬
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
347 Cytokine-cytokine receptor interaction 💬
1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
348 Cytokine-cytokine receptor interaction 💬
1件: CSF1 💬